Lively's Extension Talks Hinge on a Foot That Won't Stop Failing

The Mavericks and Dereck Lively II are in early-stage talks on a rookie scale extension, with the deadline set for October 28, roughly when the 2026/27 season tips off. If no deal closes by then, Lively heads to restricted free agency next summer—a narrowing window that puts real pressure on Dallas to decide whether the 22-year-old center is worth a guaranteed multi-year commitment or a gamble on health that's already cashed in twice.

Lively's durability profile has become the sport's clearest cautionary tale. After a sterling All-Rookie second-team season in 2023/24—55 games, 8.8 PPG, 6.9 RPG, a true-shooting clip near 75%—he appeared in 36 contests the following year before right foot stress fractures forced surgery in July 2025. He was cleared for 2025/26 opening night but managed only seven games before December season-ending surgery on the same foot. The timeline is brutal: 19 months of right-side lower-body failure across two separate procedures, with the most recent one just seven months in the rearview. As of late June, Lively was cleared to walk but hadn't been cleared to run or jump.

Dallas faces a calculus that most teams avoid: paying for a prospect's ceiling when the body is actively signaling a floor. Lively's rookie playoff run—21 games, 7.9 PPG, 7.4 RPG in the Finals run—proved he had a role in contention. But the team also knows his on-court footprint depends entirely on staying upright for more than a month at a time, which he hasn't done since April 2025. The restricted free agent market will offer an escape hatch if Dallas wants one: set a tender low enough to let him walk, or let another team test whether his efficiency (74.5% TS in his healthy sample) justifies the risk at scale. Either way, this extension deadline forces Dallas to separate optimism from evidence.

For bettors, Lively's availability—or lack thereof—carries forward implications for Dallas' bench depth and rim protection. If he's unavailable again, the team's back-line center minutes default to less efficient reserves, which subtly pushes Mavs team totals and spreads down. But the extension negotiation is primarily a front-office signal game: if Dallas locks him in, they're betting he's been de-risked enough to bet against the next 19-month pattern. If they let him walk or low-ball him, they're admitting the injury risk is priced in their favor, not his. Either way, the market will react to the outcome within hours. Watch for injury updates in September and early October. If Lively gets cleared for on-court activity—shooting, running, 5-on-5 work—the extension odds shift sharply in his favor, and Dallas' rotational stability improves. Watch for the opposite too: if September rehab reports go quiet or stall, the extension talks will cool, and so will projections for his 2026/27 minutes.

The prop angle is indirect but material. Lively's availability unlocks efficiency gains for players around him—pick-and-roll gravity, alley-oop opportunity, spacing relief for perimeter-heavy lineups like Dallas runs. If he's in and healthy, Mavericks bench production efficiency ticks up. If he's out again or limited, team totals and bench scoring props compress. The core read: his extension decision by late October is a five-week window to track whether a 12th-overall pick's body finally cooperates with his draft capital. If it doesn't, Mavs totals deserve discount pricing through 2026/27.